205 related articles for article (PubMed ID: 29333526)
1. Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
Pisapia DJ; Salvatore S; Pauli C; Hissong E; Eng K; Prandi D; Sailer VW; Robinson BD; Park K; Cyrta J; Tagawa ST; Kossai M; Fontugne J; Kim R; Sigaras A; Rao R; Pancirer D; Faltas B; Bareja R; Molina AM; Nanus DM; Rajappa P; Souweidane MM; Greenfield J; Emde AK; Robine N; Elemento O; Sboner A; Demichelis F; Beltran H; Rubin MA; Mosquera JM
JCO Precis Oncol; 2017; 2017():. PubMed ID: 29333526
[TBL] [Abstract][Full Text] [Related]
2. Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression.
Xie T; Musteanu M; Lopez-Casas PP; Shields DJ; Olson P; Rejto PA; Hidalgo M
PLoS One; 2015; 10(11):e0142631. PubMed ID: 26555578
[TBL] [Abstract][Full Text] [Related]
3. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
4. Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.
Beg S; Bareja R; Ohara K; Eng KW; Wilkes DC; Pisapia DJ; Zoughbi WA; Kudman S; Zhang W; Rao R; Manohar J; Kane T; Sigouros M; Xiang JZ; Khani F; Robinson BD; Faltas BM; Sternberg CN; Sboner A; Beltran H; Elemento O; Mosquera JM
Transl Oncol; 2021 Jan; 14(1):100944. PubMed ID: 33190043
[TBL] [Abstract][Full Text] [Related]
5. Increasing value of autopsies in patients with brain tumors in the molecular era.
Ahrendsen JT; Filbin MG; Chi SN; Manley PE; Wright KD; Bandopadhayay P; Clymer JR; Yeo KK; Kieran MW; Jones R; Lidov HG; Ligon KL; Alexandrescu S
J Neurooncol; 2019 Nov; 145(2):349-355. PubMed ID: 31571114
[TBL] [Abstract][Full Text] [Related]
6. Post-mortem Plasma Cell-Free DNA Sequencing: Proof-of-Concept Study for the "Liquid Autopsy".
Takai E; Maeda D; Li Z; Kudo-Asabe Y; Totoki Y; Nakamura H; Nakamura A; Nakamura R; Kirikawa M; Ito Y; Yoshida M; Inoue T; Habuchi T; Ikoma S; Katoh H; Kato M; Shibata T; Ishikawa S; Yachida S; Goto A
Sci Rep; 2020 Feb; 10(1):2120. PubMed ID: 32034265
[TBL] [Abstract][Full Text] [Related]
7. Quantification of nucleic acid quality in postmortem tissues from a cancer research autopsy program.
Fan J; Khanin R; Sakamoto H; Zhong Y; Michael C; Pena D; Javier B; Wood LD; Iacobuzio-Donahue CA
Oncotarget; 2016 Oct; 7(41):66906-66921. PubMed ID: 27602498
[TBL] [Abstract][Full Text] [Related]
8. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL
Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021
[TBL] [Abstract][Full Text] [Related]
9. Mutational profiles of breast cancer metastases from a rapid autopsy series reveal multiple evolutionary trajectories.
Avigdor BE; Cimino-Mathews A; DeMarzo AM; Hicks JL; Shin J; Sukumar S; Fetting J; Argani P; Park BH; Wheelan SJ
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263308
[TBL] [Abstract][Full Text] [Related]
10. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
Savas P; Teo ZL; Lefevre C; Flensburg C; Caramia F; Alsop K; Mansour M; Francis PA; Thorne HA; Silva MJ; Kanu N; Dietzen M; Rowan A; Kschischo M; Fox S; Bowtell DD; Dawson SJ; Speed TP; Swanton C; Loi S
PLoS Med; 2016 Dec; 13(12):e1002204. PubMed ID: 28027312
[TBL] [Abstract][Full Text] [Related]
11. Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsies.
Huang X; Qiao Y; Brady SW; Factor RE; Downs-Kelly E; Farrell A; McQuerry JA; Shrestha G; Jenkins D; Johnson WE; Cohen AL; Bild AH; Marth GT
Genome Med; 2021 Oct; 13(1):170. PubMed ID: 34711268
[TBL] [Abstract][Full Text] [Related]
12. Patient-Derived Organoids of Cholangiocarcinoma.
Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
[TBL] [Abstract][Full Text] [Related]
13. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards.
Rieke DT; de Bortoli T; Horak P; Lamping M; Benary M; Jelas I; Rüter G; Berger J; Zettwitz M; Kagelmann N; Kind A; Fabian F; Beule D; Glimm H; Brors B; Stenzinger A; Fröhling S; Keilholz U
BMC Med; 2022 Oct; 20(1):367. PubMed ID: 36274133
[TBL] [Abstract][Full Text] [Related]
15. A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium.
Mueller S; Jain P; Liang WS; Kilburn L; Kline C; Gupta N; Panditharatna E; Magge SN; Zhang B; Zhu Y; Crawford JR; Banerjee A; Nazemi K; Packer RJ; Petritsch CK; Truffaux N; Roos A; Nasser S; Phillips JJ; Solomon D; Molinaro A; Waanders AJ; Byron SA; Berens ME; Kuhn J; Nazarian J; Prados M; Resnick AC
Int J Cancer; 2019 Oct; 145(7):1889-1901. PubMed ID: 30861105
[TBL] [Abstract][Full Text] [Related]
16. Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients.
Chen J; Facchinetti F; Braye F; Yurchenko AA; Bigot L; Ponce S; Planchard D; Gazzah A; Nikolaev S; Michiels S; Vasseur D; Lacroix L; Tselikas L; Nobre C; Olaussen KA; Andre F; Scoazec JY; Barlesi F; Soria JC; Loriot Y; Besse B; Friboulet L
Ann Oncol; 2022 Apr; 33(4):434-444. PubMed ID: 35066105
[TBL] [Abstract][Full Text] [Related]
17. Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma.
Zhao P; Chen H; Wen D; Mou S; Zhang F; Zheng S
Cancer Commun (Lond); 2018 Aug; 38(1):54. PubMed ID: 30139386
[TBL] [Abstract][Full Text] [Related]
18. A community-based lung cancer rapid tissue donation protocol provides high-quality drug-resistant specimens for proteogenomic analyses.
Boyle TA; Quinn GP; Schabath MB; Muñoz-Antonia T; Saller JJ; Duarte LF; Hair LS; Teer JK; Chiang DY; Leary R; Wong CC; Savchenko A; Singh AP; Charette L; Mendell K; Gorgun G; Antonia SJ; Chiappori AA; Creelan BC; Gray JE; Haura EB
Cancer Med; 2020 Jan; 9(1):225-237. PubMed ID: 31747139
[TBL] [Abstract][Full Text] [Related]
19. Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience.
Marks LJ; Oberg JA; Pendrick D; Sireci AN; Glasser C; Coval C; Zylber RJ; Chung WK; Pang J; Turk AT; Hsiao SJ; Mansukhani MM; Glade Bender JL; Kung AL; Sulis ML
Front Pediatr; 2017; 5():265. PubMed ID: 29312904
[TBL] [Abstract][Full Text] [Related]
20. Molecular Profiles of Brain Metastases: A Focus on Heterogeneity.
Ali S; Górska Z; Duchnowska R; Jassem J
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
